China Establishes Fast-Track Approval Process For New Flu Anti-Virals
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities have made plans to fast-track the nation's drug-approval process, but only for products aimed at treating an epidemic, beginning with the A(H1N1) swine flu. China's State FDA established a team of review experts to be ready to speed the process for those drugs without sacrificing quality issues. A spokeswoman said the new procedures are to be used for new drugs only when the public health is threatened. (Click here for more